SCIENTIFIC BACKGROUND

DES, DSC2, DSG2, DSP, JUP, LMNA, PKP2, PLN, TGFB3, TMEM43

Arrythmogenic right ventricular cardiomyopathy (ARVC) is a mostly autosomal dominant inherited disease of the heart muscle in which the myocardium is progressively replaced by fatty and connective tissue. The connective tissue remodeling, which mainly affects the right ventricle, initially leads to a disturbance of the stimulus conduction with ventricular arrythmias, palpitations or syncope. The ECG typically shows epsilon waves and an inverted T-wave with broadened QRS complex in right precordial recording.

 

The arrythmias that can lead to sudden cardiac death are usually triggered by physical exertion. About one third of the index patients die suddenly between the ages of 14-20 years and this age seems to be a vulnerable period for fatal arrythmias. However, half of the carriers do not develop clinical symptoms until over 50 years of age and about one third do not become ill until old age. The frequency of ARVC is estimated at 1:5,000, and about half of the cases show a familial clustering. More than ten different forms of ARVC have now been documented.

 

The most common forms are caused by variants in genes that code for components of the desmosomes (cell-cell connections). Molecular genetic analysis of the genes that encode desmoplakine (DSP), plakophilin-2 (PKP2) and desmoglein-2 (DSG2) reveals variants in about 50-60% of patients. In about 5% of cases, the hereditary form of ARVC is caused by variants of other desmosomal protein genes such as plakoglobin (JUP) and desmocollin-2 (DSC2), as well as other genes such as transmembrane protein 43 (TMEM43) and transforming growth factor beta-3 (TGFB3). To date, no genetic cause can be proven in about 40% of ARVC cases.

 

References

Hall et al. 2018, Eur J Hum Genet doi.org/10.1038/s41431-018-0169- 4 / Walsh et al. 2017, Genet Med 19:192 / Medeiros-Domingo et al. 2016, Europace pii: euw098 / Bhonsale et al. 2015, Eur Heart J epub Jan / Schulze-Bahr et al. 2015, Kardiologe DOI 10.1007/s12181-014-0636-2 / Campuzano et al. 2013, J Med Genet 50:280 / Quarta et al. 2011, Circulation 123:2701 / Ackerman et al. 2011, Europace 13:1077

GENES

DES, DSC2, DSG2, DSP, JUP, LMNA, PKP2, PLN, TGFB3, TMEM43
How to order

LATEST ARTICLES

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of ...

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access...

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is...

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti...

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more

Cardiovascular diseases affect the heart and blood vessels and are a leading cause of illness and death. Some are hereditary, and genetic testing can...

Read more

A recent study tracked molecular changes in 108 people over time, revealing that aging involves critical shifts around ages 44 and 60. These changes ...

Read more